|
MANTLE CELL LYMPHOMA - Molecular characterization and identification of biological risk factors in mantle cell lymphoma (LIFE QUALITY) (2001-01-01 - 2003-12-31)
(»add to infobox)
 
|
Juergen BUSSE,
Karin-Barbara SPINDLER,
Gert MIKKELSEN,
Holger BAUMANN,
Christof STAUDT,
Bruno FORSTER,
Jan Willem VAN DER LINDEN,
David WESTLAKE,
Peter VOOIJS,
Albert SCHIRA,
Helmut SHÜTTIG,
Joaquim AZCON,
Marc DECHAVANNE,
Stefano PILERI
|
|
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE212 - München, Kreisfreie Stadt) (Germany),
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (DEF02 - Kiel, Kreisfreie Stadt) (Germany),
COPENHAGEN UNIVERSITY HOSPITAL (DK001 - København og Frederiksberg kommuner) (Denmark),
HANNOVER MEDICAL SCHOOL (DE921 - Hannover, Krfr.St.) (Germany),
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN (DE712 - Frankfurt am Main, Kreisfreie Stadt) (Germany),
JULIUS-MAXIMILIANS UNIVERSITAET WUERZBURG (DE263 - Würzburg, Kreisfreie Stadt) (Germany),
UNIVERSITEIT LEIDEN (NL331 - Agglomeratie Leiden en Bollenstreek) (Netherlands),
QUEEN MARY & WESTFIELD COLLEGE (UK550 - Greater London) (Great Britain),
STICHTING KATHOLIEKE UNIVERSITEIT (NL223 - Arnhem/Nijmegen) (Netherlands),
UNIVERSITAET ULM (DE144 - Ulm, Stadtkreis) (Germany),
UNIVERSITAETSKLINIKUM LUEBECK (DEF03 - Lübeck, Kreisfreie Stadt) (Germany),
UNIVERSITAT DE BARCELONA (ES511 - Barcelona) (Spain),
UNIVERSITE CLAUDE BERNARD LYON 1 (FR716 - Rhône) (France),
UNIVERSITY OF BOLOGNA (IT405 - Bologna) (Italy) |
| BUDGET: | 1.724.000 € |
| FUNDING: | 1.699.999 € |
| INSTRUMENT: | Cost Sharing Contracts |
| PROGRAMME: | LIFE QUALITY |
|
|
|
In the previous Biomed II program, a European concerted action of clinicians and pathologists has been established, to define the clinical characteristics as well as the precise morphological criteria for the sub classification of MCL. Based on this established European infrastructure, we are planning to extend our focus of research to the basic molecular risk factors in MCL. This research network is structured into 4 differentially focussed work packages, each of tem representing an international collaboration of several research groups:(1) primary genetic alterations and markers of maturation
(2) Cell cycle deregulation in MCL
(3) Secondary alterations and sequential analysis in MCL
(4) Functional studies of MCL.
This approach will identify high-risk patients and finally direct the development of future innovative treatment options.
|
| PERSONS (14/14) |
|
Juergen BUSSE (Contact / LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (DE212 - München, Kreisfreie Stadt) (Germany))
Karin-Barbara SPINDLER (Contact / CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL (DEF02 - Kiel, Kreisfreie Stadt) (Germany))
Gert MIKKELSEN (Contact / COPENHAGEN UNIVERSITY HOSPITAL (DK001 - København og Frederiksberg kommuner) (Denmark))
Holger BAUMANN (Contact / HANNOVER MEDICAL SCHOOL (DE921 - Hannover, Krfr.St.) (Germany))
Christof STAUDT (Contact / JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN (DE712 - Frankfurt am Main, Kreisfreie Stadt) (Germany))
Bruno FORSTER (Contact / JULIUS-MAXIMILIANS UNIVERSITAET WUERZBURG (DE263 - Würzburg, Kreisfreie Stadt) (Germany))
Jan Willem VAN DER LINDEN (Contact / UNIVERSITEIT LEIDEN (NL331 - Agglomeratie Leiden en Bollenstreek) (Netherlands))
David WESTLAKE (Contact / QUEEN MARY & WESTFIELD COLLEGE (UK550 - Greater London) (Great Britain))
Peter VOOIJS (Contact / STICHTING KATHOLIEKE UNIVERSITEIT (NL223 - Arnhem/Nijmegen) (Netherlands))
Albert SCHIRA (Contact / UNIVERSITAET ULM (DE144 - Ulm, Stadtkreis) (Germany))
Helmut SHÜTTIG (Contact / UNIVERSITAETSKLINIKUM LUEBECK (DEF03 - Lübeck, Kreisfreie Stadt) (Germany))
Joaquim AZCON (Contact / UNIVERSITAT DE BARCELONA (ES511 - Barcelona) (Spain))
Marc DECHAVANNE (Contact / UNIVERSITE CLAUDE BERNARD LYON 1 (FR716 - Rhône) (France))
Stefano PILERI (Contact / UNIVERSITY OF BOLOGNA (IT405 - Bologna) (Italy))
| RELATED NAVIGATION AREA(S) (2/2) |
|
Cancerology
FP5 Life Quality
|
|
|
|
